| ADAM | Androgen Deficiency in the Aging Male |
| AMS | Aging Males’ Symptoms |
| ART | assisted reproductive technology |
| ASRM | American Society for Reproductive Medicine |
| AUA | American Urological Association |
| CI | confidence interval |
| EAU | European Association of Urology |
| FSH | follicle-stimulating hormone |
| GIP | glucose-dependent insulinotropic polypeptide |
| GLP-1 | glucagon-like peptide-1 |
| GRADE | Grading of Recommendations Assessment, Development and Evaluation |
| HbA1c | glycated hemoglobin |
| hCG | human chorionic gonadotropin |
| HOMA | homeostasis model assessment |
| ICSI | intracytoplasmic sperm injection |
| IIEF-5 | five-item International Index of Erectile Function |
| LH | luteinizing hormone |
| PRISMA | Preferred Reporting Items for Systematic Reviews and Meta-Analyses |
| ROBINS-I | Risk Of Bias In Non-randomized Studies of Interventions |
| SANRA | Scale for the Assessment of Narrative Review Articles |
| SD | standard deviation |
| SERM | selective estrogen receptor modulator |
| SGLT2 | sodium–glucose cotransporter-2 |
| SHBG | sex hormone-binding globulin |
| SHIM | Sexual Health Inventory for Men |
| STROBE | Strengthening the Reporting of Observational Studies in Epidemiology |
| T2DM | type 2 diabetes mellitus |